Morgan Stanley stock price drops nearly 2% as Wall Street wobbles — what investors are watching

Morgan Stanley stock price drops nearly 2% as Wall Street wobbles — what investors are watching

New York, Feb 3, 2026, 15:33 EST — Regular session

  • Morgan Stanley shares dip, ending a brief winning run.
  • Financials and dealmakers remain under pressure amid a broader risk-off mood.
  • Traders focus on the yield curve story amid a packed earnings schedule.

Morgan Stanley (MS) shares slipped $3.38, or 1.8%, closing at $181.72 in late afternoon trading Tuesday.

The decline came after Monday’s 1.26% jump to $185.10, ending a streak of three straight gains. The stock still trades roughly 4% under its 52-week peak of $192.68, reached Jan. 16, according to MarketWatch data. (MarketWatch)

The selloff hit as U.S. stocks fell on concerns that new AI tools might pressure software makers and upend expectations for tech spending. A partial U.S. government shutdown has delayed crucial jobs data, fueling uncertainty. Art Hogan of B. Riley Wealth noted investors are “seeing a lot of software companies … get hit,” while John Campbell at Allspring Global Investments described the market as “expensive” and “priced for perfection.” (Reuters)

In the financial sector, the Financial Select Sector SPDR ETF dropped roughly 1.1%. Goldman Sachs slid around 1.5%, but JPMorgan Chase climbed about 1.3%.

Bank shares also hinge on the yield curve—the difference between short- and long-term Treasury rates. A steeper curve tends to boost lenders by expanding the gap between borrowing costs and loan rates. Yet, rising long-term yields can tighten financial conditions and weigh on risk assets.

Investors are stepping up bets on a steeper yield curve as Kevin Warsh edges closer to the Federal Reserve’s top spot. Markets are juggling expectations of rate cuts alongside a shrinking Fed balance sheet. Jim Barnes from Bryn Mawr Trust noted these two forces can “go in opposite directions.” Rate futures still price in about two quarter-point cuts in 2026, with the first likely at the June 16-17 meeting, Reuters reports. (Reuters)

For Morgan Stanley, where markets activity and wealth fees dominate, daily mood swings can weigh just as heavily as the yield curve.

On Monday, Morgan Stanley Finance LLC submitted a prospectus supplement for a new offering, continuing its regular issuance of market-linked products. (SEC)

Apartment Investment and Management Company revealed in a separate filing that it hired Morgan Stanley as its lead financial adviser on a potential deal, turning to the bank again as it advanced plans for a sale and liquidation. (SEC)

The downside is clear. If the shutdown fight drags on and rate volatility spikes, deal timelines could slip, and clients might avoid risk. That’s a fast track to shrinking underwriting and advisory fees, and a slower drag on wealth inflows if markets remain unsettled.

Earnings are next on the docket: Alphabet is set to report after Wednesday’s close, with Amazon following after Thursday’s bell. These two reports could shift risk appetite as the week wraps up. (Investopedia)

Stock Market Today

  • NRG Energy Shares Seen Undervalued After Recent Pullback, DCF Analysis Shows
    February 3, 2026, 4:07 PM EST. NRG Energy (NRG) shares recently declined 10.3% over 30 days to $149.11, despite a strong 47.0% gain over the past year. The pullback follows years of significant growth in the U.S. utilities sector. A discounted cash flow (DCF) model estimates NRG's intrinsic value at about $570.42 per share, implying it is 73.9% undervalued based on future cash flow projections. The model anticipates free cash flow reaching $5.4 billion by 2035. NRG scores 3 out of 6 on Simply Wall St's valuation checklist, signaling mixed signals. The valuation suggests potential investment opportunities if the company meets growth expectations amid market volatility and sector pressures.
AbbVie stock ticks up ahead of earnings after Rinvoq vitiligo filing—what investors watch next
Previous Story

AbbVie stock ticks up ahead of earnings after Rinvoq vitiligo filing—what investors watch next

LyondellBasell stock jumps as RBC lifts target — what LYB investors are watching next
Next Story

LyondellBasell stock jumps as RBC lifts target — what LYB investors are watching next

Go toTop